Dr
David
Selby

Patent Director

Leeds Office Manchester Office

Chemistry

Telephone. +44(0) 113 233 0100
Mobile. +44(0) 758 599 7412
Email. [email protected]

Experience

David's practice is predominantly in the areas of chemical and biomedical research tools, including analytical instrumentation, and pharmaceuticals. David's experience in these areas includes GB and European patent prosecution, drafting and international portfolio management for large corporations and universities. David also has significant experience in oppositions and appeals before the EPO. Other subject matter that falls within David's practice includes medical devices, nanotechnology and advanced materials.

David has a degree in Chemistry and a doctorate in Chemistry, as well as a law degree from the University of New South Wales. His research experience included the construction of a novel mass spectrometer, and the application of mass spectrometry to proteomics and analysis of post-translation modification of proteins. His research experience thus covers development of instrumentation and methods of chemical analysis, through to characterisation of biological materials.

David qualified as a solicitor in Sydney, Australia, where he worked in IP litigation and has also qualified as a solicitor in England and Wales. David's practice draws on this combination of scientific and legal experience, with his understanding of enforcement and opposition informing his patent drafting and prosecution, and assisting David in providing commercially focused advice in all areas of his practice.

Specialisms

  • Pharmaceutical technologies
  • Physical chemistry
  • Polymer chemistry

Industries

  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patent term extensions & SPCs
  • Patents
  • Portfolio management

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

BSc in Chemistry with Hons 1

LLB

Bachelors of laws, UNSW

PHD

Chemistry

Related News

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Tarilian Laser Technologies - a case study in due diligence

When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …

Read article

Health-conscious IP strategies

Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details
Event - 1st December 2021

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …

Event details

Lab-grown meat – not yet on the menu

It is now eight years since the first lab-grown burger was unveiled by a team of scientists at Maastricht University, but since then the path to market has been slow. …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.